Updates

CSRXP APPLAUDS PRESIDENT BIDEN’S COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES AND CALL FOR CONGRESS TO ACT

Aug 12, 2021

Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver Read More

CSRXP STATEMENT ON U.S. SENATE PASSAGE OF REBATE RULE DELAY & REFUND ACT AS PART OF BIPARTISAN INFRASTRUCTURE BILL

Aug 10, 2021

Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate Read More

SECOND OPINION: BIG PHARMA TROTS OUT BOGUS R&D DEFENSE TO OPPOSE TAX

Aug 9, 2021

Remembering Drug Companies Spend Their Profits on Shareholders and Marketing Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA, SANOFI, MERCK, ABBVIE, ELI LILLY & AMGEN

Aug 6, 2021

Q2 Earnings Reports Continue to Show Pandemic Price Hikes Profitable for Brand Read More

BIG PHARMA EARNINGS WATCH: PFIZER, GLAXO SMITH KLINE, BRISTOL MYERS SQUIBB

Jul 30, 2021

Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of Read More

CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOLOGIC FOR INSULIN

Jul 29, 2021

Interchangeable Products Will Help Increase Prescription Drug Competition and Read More

CSRXP: SENATE JUDICIARY COMMITTEE CRACKS DOWN ON BIG PHARMA PATENT ABUSE

Jul 29, 2021

Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’ Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, NOVARTIS, ROCHE

Jul 22, 2021

New Round of Earnings Reports Show Big Pharma Companies Riding High on Massive Read More

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS

Jul 22, 2021

Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower Read More

THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES

Jul 14, 2021

Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control Read More

DOSE OF REALITY: LAWMAKERS TO PROBE BIG PHARMA PATENT ABUSE AS INNOVATION EXCUSES CRUMBLE

Jul 13, 2021

U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for Read More

CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE

Jul 9, 2021

Campaign Looks Forward to Working with Administration and Congress to Crack Read More